Currently Viewing:
Currently Reading
What We're Reading: Policy on MRI Scans; Websites Illegally Selling Drugs; Alzheimer's Drug Failure
September 26, 2017 – AJMC Staff
New Advance Value Framework Offered as a Decision-Support Tool for Reimbursement
September 25, 2017 – Surabhi Dangi-Garimella, PhD
Study Finds Long-Term Prescription Opioid Use Is Increasing in the United States
September 25, 2017 – Alison Rodriguez
Study Evaluates Value of Precision Oncology Decision Support Tool
September 22, 2017 – Surabhi Dangi-Garimella, PhD
This Week in Managed Care: September 22, 2017
September 22, 2017
What We're Reading: Relief From Medicaid Cuts; Amazon and PBMs; Safety Net Hospital Payments
September 22, 2017 – AJMC Staff
What We're Reading: CVS Limiting Opioid Prescriptions; ACA Vote Coming; Florida Nursing Home
September 21, 2017 – AJMC Staff
Physicians Develop Guidelines to Manage CAR T-Cell Toxicity
September 20, 2017 – Surabhi Dangi-Garimella, PhD
CMS Innovation Center Seeks New Direction to Encourage Competition, Flexibility
September 20, 2017 – Laura Joszt

What We're Reading: Policy on MRI Scans; Websites Illegally Selling Drugs; Alzheimer's Drug Failure

AJMC Staff

Directing Patients Where to Get MRIs

A new policy with Anthem will require patients get magnetic resonance imaging or computed tomography scans at independent imaging centers. The change is supposed to reduce costs—hospital imaging is more expensive than imaging done at freestanding centers—but critics say it will fragment care, according to Kaiser Health News. Imaging tests are already subject to preapproval by Anthem, and now the insurer will not only decide whether or not the scan is medically necessary, but where it should be performed. The exception to the rule is rural areas that don’t have at least 2 other non-hospital imaging centers available.


FDA Cracks Down on Websites Illegally Selling Drugs

More than 500 websites selling unapproved versions of prescription medications have been targeted by the FDA. According to The Washington Post, the effort was part of a global operation organization by Interpol. The websites were selling opioids, antibiotics, and injectable epinephrine, and the crackdown involved 123 countries. The FDA largely focused on websites illegally selling opioids online and shipping them through the United States postal system.


Alzheimer’s Disease Treatment Falls Short

In a large trial, a potential drug to reduce symptoms of Alzheimer’s disease has failed. The drug was the latest potential treatment for Alzheimer’s disease to fall short in trial, reported STAT. Intepirdine by Axovant Sciences was not supposed to be a cure; instead, the drug was expected to delay symptoms of Alzheimer’s and slow cognitive decline. The trial included 1300 patients with mild to moderate Alzheimer’s and combined intepirdine and Aricept, a generic memory booster.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up